Andrea Cusack is a senior international life sciences executive with 25+ years’ experience across pharma, biotech and CDMOs (GSK, Catalent, West Pharma, leon nanodrugs). She is CEO of Nebuflow and a strategic board advisor to Instapill. Andrea brings end-to-end expertise across Chemistry, Manufacturing and Controls (CMC), from early development through commercialisation, spanning a wide range of dosage forms and delivery technologies for both small and large molecules. She provides effective oversight of development, manufacturing strategy and operational risk in complex growth-stage environments.
